TAG:
pathology associates medical laboratories
PAML to Enter Kentucky With New Laboratory JV
By Robert Michel | From the Volume XVII No. 4 – March 21, 2011 Issue
CEO SUMMARY: This latest laboratory joint venture, in partnership with Saint Joseph Health System, gives Pathology Associates Medical Laboratories, LLC (PAML), a solid presence in Kentucky’s laboratory testing marketplace. Over the past 10 years, PAML, which is based in the Pac…
Solstas Lab Partners, DNA Direct, Pathology, Inc., Slone Partners, PAML
By Robert Michel | From the Volume XVIII No. 2 – February 7, 2011 Issue
SPECTRUM-CARILION NOW WILL BE CALLED SOLSTAS LAB PARTNERS IT IS THE NEXT STEP IN THE INTEGRATION of Spectrum Laboratory Network and Carilion Laboratories. Effective February 1, 2011, their combined businesses will use the name Solsta…
December 27, 2010 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVII No. 18 – December 27, 2010 Issue
As the year ends, a bit of humor is in order and the recent dust-up involving Michael Moore’s healthcare documentary, titled “Sicko,” and a State Department cable posted on wikileaks.com may be just the item. About a week ago, The Guardian newspaper in Manchester, England, rep…
Our Top Ten Lab Stories Highlight Major Changes
By Robert Michel | From the Volume XVII No. 17 – December 6, 2010 Issue
CEO SUMMARY: What makes 2010 a watershed year for the laboratory testing industry is enactment of the 2,700-page Patient Protection and Affordable Care Act (PPACA). Even if parts of this bill are repealed, the remaining parts of the massive legislation will trigger major changes …
Two New Lab Companies Will Open in L.A. & Denver
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO SUMMARY: It is unprecedented for two multi-billion-dollar health systems to announce laboratory testing outreach joint ventures just days apart. In Los Angeles, Providence Health & Services will partner with PAML to start a commercial lab company in the San Fernando Valle…
More Hospitals Consider PAML’s Lab JV Model
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO SUMMARY: One joint venture at a time, PAML is convincing hospital and health system CEOs about the benefits of building a thriving laboratory outreach business. For their part, facing budget cutbacks and a decline in Medicare reimbursement, more hospital administrato…
New Cycle Begins for Lab and Pathology Acquisitions
By R. Lewis Dark | From the Volume XVII No. 3 – February 15, 2010 Issue
THERE’S A NEW TRANSITION JUST GETTING STARTED in the laboratory testing industry. For the past two decades, laboratory acquisition activity has primarly centered around independent clinical laboratories—often owned by local pathologists. This was true in both the size of the transactions and in t…
2009’s Top Ten Lab Stories Reflect Some Good, Bad
By Robert Michel | From the Volume XVI No. 17 – December 14, 2009 Issue
CEO SUMMARY: As the closing year of the first decade of the new century and the new millennium, 2009 brought neither disruption nor upheaval to the majority of laboratories in the United States. Rather, it was marked by at least two themes. One was how public disclosure of problems with l…
Catholic Health Initiatives Ramps Up Lab Outreach
By Robert Michel | From the Volume XVI No. 17 – December 14, 2009 Issue
CEO SUMMARY: Catholic Health Initiatives (CHI) wants to expand its presence in outpatient and outreach services. It sees hospital laboratory outreach programs as a key component of this strategy. It will use an equity investment in Pathology Associates Medical Laboratories (PAML) as the f…
PAML’s “Magic Touch” with Hospital Lab JVs
By R. Lewis Dark | From the Volume XVI No. 15 – November 02, 2009 Issue
IMAGINE FOR A MOMENT THAT ONE OF THE TWO BLOOD BROTHERS inked a deal: 1) to set up a series of hospital laboratory joint ventures with a multi-billion health system that operated 50 to 100 hospitals in 15 to 20 states; and, 2) to be a primary source of esoteric and reference testing to all those hosp…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized